Avenue Therapeutics (ATXI) Stock Chart & Stock Price History → Bill Clinton Backing Biden Replacement??? (From The Freeport Society) (Ad) Free ATXI Stock Alerts $3.43 +0.04 (+1.18%) (As of 06/11/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSustainabilityTrends Avenue Therapeutics Stock Price Performance5 Day Performance+1.48%1 Month Performance-14.25%3 Month Performance-73.85%6 Month Performance-70.30%Year-To-Date Performance-71.59%1 Year Performance-96.09% Receive ATXI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avenue Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsTiny Defense Firm Set for Huge Gains with New US ContractOne tiny defense firm just won a groundbreaking US military contract… That could hand early investors gains of up to 35,960%.Click here for the ticker>>> ATXI Stock Chart for Wednesday, June, 12, 2024 ATXI Chart by TradingView Avenue Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/11/2024$3.39$3.43+1.18%$3.50$3.2811,066 shs$3.22 million06/10/2024$3.38$3.39+0.30%$3.56$3.2713,390 shs$3.19 million06/07/2024$3.60$3.38-6.11%$3.69$3.3461,388 shs$3.18 million06/06/2024$3.76$3.60-4.26%$3.82$3.6023,247 shs$3.38 million06/05/2024$3.75$3.76+0.27%$3.86$3.6711,994 shs$3.53 million06/04/2024$3.78$3.75-0.79%$3.88$3.6113,110 shs$3.53 million Get the Latest News and Ratings for ATXI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avenue Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/03/2024$3.44$3.78+9.88%$3.98$3.3062,168 shs$3.56 million05/31/2024$3.61$3.44-4.71%$3.67$3.3527,539 shs$3.23 million05/30/2024$3.73$3.61-3.22%$3.81$3.5918,065 shs$3.39 million05/29/2024$3.71$3.73+0.54%$3.99$3.7019,504 shs$3.51 million05/28/2024$3.62$3.71+2.49%$3.79$3.678,883 shs$3.49 million05/27/2024$3.62$3.62$3.73$3.6215,800 shs$3.40 million05/24/2024$3.62$3.62$3.73$3.6215,848 shs$3.40 million05/23/2024$3.71$3.62-2.43%$3.89$3.6240,057 shs$2.14 million05/22/2024$3.80$3.71-2.37%$3.95$3.6311,012 shs$2.19 million05/21/2024$3.81$3.80-0.26%$3.97$3.6522,776 shs$2.24 million05/20/2024$3.73$3.81+2.14%$3.88$3.6043,265 shs$2.25 million05/17/2024$3.63$3.73+2.75%$3.98$3.6338,431 shs$2.20 million05/16/2024$3.65$3.63-0.55%$3.80$3.6045,073 shs$2.14 million05/15/2024$3.84$3.65-4.95%$3.95$3.6047,264 shs$2.15 million05/14/2024$3.95$3.84-2.78%$4.00$3.5269,364 shs$2.27 million05/13/2024$4.00$3.95-1.25%$3.99$3.8050,190 shs$2.33 million05/10/2024$4.15$4.00-3.61%$4.29$4.0087,380 shs$2.36 million05/09/2024$4.40$4.15-5.68%$4.37$4.1280,934 shs$2.45 million05/08/2024$4.20$4.40+4.76%$4.72$4.15205,509 shs$2.60 million05/07/2024$4.51$4.20-6.87%$5.97$4.041.09 million shs$2.48 million05/06/2024$4.78$4.51-5.65%$4.83$4.5058,052 shs$2.66 million05/03/2024$4.80$4.78-0.42%$5.45$4.77285,597 shs$2.82 million05/02/2024$4.76$4.80+0.84%$4.95$4.6229,660 shs$2.83 million05/01/2024$5.01$4.76-4.99%$5.08$4.5562,038 shs$2.81 million04/30/2024$4.51$5.01+10.97%$5.21$4.38155,199 shs$2.96 million04/29/2024$6.20$4.51-27.18%$5.35$4.51217,699 shs$2.66 million04/26/2024$8.78$6.20-29.34%$8.83$5.78234,022 shs$274.41 million04/25/2024$7.07$8.78+24.07%$9.00$6.39132,076 shs$5.18 million04/24/2024$10.05$7.07-29.63%$7.88$6.68163,795 shs$4.17 million04/23/2024$9.76$10.05+3.00%$10.13$9.603,771 shs$5.93 million04/22/2024$9.75$9.76+0.08%$10.31$8.5521,428 shs$5.76 million04/19/2024$10.10$9.75-3.42%$10.33$9.384,274 shs$5.75 million04/18/2024$10.13$10.10-0.37%$10.30$9.833,869 shs$5.96 million04/17/2024$9.87$10.13+2.66%$10.43$9.7010,809 shs$5.98 millionTiny Defense Firm Set for Huge Gains with New US Contract (Ad)One tiny defense firm just won a groundbreaking US military contract… That could hand early investors gains of up to 35,960%.Click here for the ticker>>>04/16/2024$9.38$9.87+5.28%$10.13$9.295,690 shs$5.83 million04/15/2024$10.16$9.38-7.75%$10.50$8.6430,895 shs$5.53 million04/12/2024$10.59$10.16-4.04%$10.85$10.143,516 shs$6.00 million04/11/2024$11.22$10.59-5.61%$11.63$10.1316,290 shs$6.25 million04/10/2024$11.02$11.22+1.84%$11.33$10.914,031 shs$6.62 million04/09/2024$11.51$11.02-4.30%$11.42$10.9310,294 shs$6.50 million04/08/2024$11.16$11.51+3.16%$11.61$10.7515,025 shs$6.79 million04/05/2024$11.03$11.16+1.22%$11.25$10.668,250 shs$6.59 million04/04/2024$11.18$11.03-1.34%$11.51$10.654,231 shs$6.51 million04/03/2024$11.25$11.18-0.67%$11.85$10.819,831 shs$6.60 million04/02/2024$11.26$11.25-0.07%$11.27$10.658,464 shs$6.64 million04/01/2024$11.06$11.26+1.76%$11.70$10.957,579 shs$6.64 million03/29/2024$11.06$11.06$11.89$10.9210,659 shs$6.53 million03/28/2024$11.45$11.06-3.34%$11.89$10.9210,487 shs$6.53 million03/27/2024$11.33$11.45+1.06%$11.66$11.126,559 shs$6.75 million03/26/2024$11.63$11.33-2.58%$11.71$10.9115,004 shs$6.68 million03/25/2024$11.34$11.63+2.51%$12.00$10.5036,685 shs$6.86 million03/22/2024$11.87$11.34-4.49%$11.81$11.0621,103 shs$2.00 million03/21/2024$11.88$11.87-0.06%$12.14$11.633,558 shs$2.10 million03/20/2024$12.00$11.88-1.00%$12.53$11.3511,493 shs$2.10 million03/19/2024$12.00$12.00$12.75$11.7810,596 shs$2.12 million03/18/2024$11.81$12.00+1.59%$12.54$11.989,684 shs$2.12 million03/15/2024$11.63$11.81+1.61%$13.13$11.4832,729 shs$2.09 million03/14/2024$12.67$11.63-8.23%$12.21$11.2528,695 shs$2.05 million03/13/2024$13.12$12.67-3.43%$13.69$12.2423,341 shs$2.24 million03/12/2024$12.15$13.12+7.96%$13.88$12.1538,642 shs$2.32 million03/11/2024$14.40$12.15-15.63%$13.39$11.7553,399 shs$2.15 million Related Companies: Chemomab Therapeutics Stock Price Chart Monopar Therapeutics Stock Price Chart Pieris Pharmaceuticals Stock Price Chart Kiora Pharmaceuticals Stock Price Chart Elevai Labs Stock Price Chart Imunon Stock Price Chart Kintara Therapeutics Stock Price Chart Guardion Health Sciences Stock Price Chart MIRA Pharmaceuticals Stock Price Chart Vaccinex Stock Price Chart Receive ATXI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avenue Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ATXI) was last updated on 6/12/2024 by MarketBeat.com Staff From Our PartnersYour Special Report - Top 7 Summer StocksSummer is almost Here! I would like to give you a special report that could help boost your portfolio this sum...StockEarnings | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredThe Hidden Tax Advantages of America’s #1 Inheritance StockWall Street Millionaire: BUY "America's #1 Legacy Stock" The man CNBC called "The Prophet" bought AAPL at $...Stansberry Research | SponsoredBill Clinton Backing Biden Replacement???Louis Navellier — a frequent guest at Mar-a-Lago — ruffled many in his own circles when he declared over a yea...The Freeport Society | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avenue Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avenue Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.